Innovative diagnostic tools for detecting rare and hidden disease, based on the world’s largest labeled patient dataset, built to be integrated into existing physician workflows and currently pursuing FDA approval.
Granted FDA Breakthrough Device Designation
Phase: Development
Phase: Development
Phase: Development
Phase: Development
Phase: Development
Phase: Development
Anumana also has a rich pipeline of AI / ML driven products for use in the interventional electrophysiology (EP) setting.
Phase: Authorization
FDA Clearance Not Required
Phase: Submission
Phase: Validation
Phase: Development
Partner with us!
We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to hello@anumana.ai
@2023 anumana, Inc. All rights reserved.